TXMD Insider Trading Activity and SEC Form 4 Filings
TXMD insider trading summary
No open-market insider purchases or sales of TherapeuticsMD, Inc. (TXMD) have been reported on SEC Form 4 in the past 12 months.
Latest TXMD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 14, 2025 | Marlan D Walker | Chief Executive Officer | Buy | $489 (490 @ $1.00) |
| Apr 14, 2025 | Tommy G Thompson | Insider | Buy | $326 (325 @ $1.00) |
| Apr 10, 2025 | Marlan D Walker | Chief Executive Officer | Buy | $1K (1,167 @ $0.86) |
| Apr 9, 2025 | Marlan D Walker | Chief Executive Officer | Buy | $994 (1,136 @ $0.87) |
| Aug 22, 2024 | Cooper C. Collins | Insider | Buy | $7K (4,094 @ $1.73) |
| Aug 21, 2024 | Cooper C. Collins | Insider | Buy | $2K (1,200 @ $1.70) |
| Dec 7, 2023 | Marlan D Walker | Chief Executive Officer | Sell | $10K (4,550 @ $2.24) |
| Dec 6, 2023 | Marlan D Walker | Chief Executive Officer | Sell | $33K (14,500 @ $2.31) |
| Apr 12, 2023 | Marlan D Walker | Chief Executive Officer | Sell | $4K (1,170 @ $3.65) |
| Jan 27, 2023 | Michael C Donegan | Prin. Fin. and Acctg. Officer | Sell | $249 (49 @ $5.09) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.